Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
August 26, 2011
PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders
S Saenger, C Goeldner, J R Frey, et al.
Amino Acids
|
October 10, 2002
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article
R Kuhn, A Pagano, N Stoehr, et al.
British Journal of Pharmacology
|
November 3, 2010
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors
P Malherbe, F Knoflach, M C Hernandez, et al.
Psychopharmacology
|
December 2, 2010
Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine
M M J Veeneman, H Boleij, M H Broekhoven, et al.
Advances in Experimental Medicine and Biology
|
June 14, 2001
Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice
S Barbieri, K Hofele, K H Wiederhold, et al.
Experimental Gerontology
|
December 13, 2000
Mouse models of alpha-synucleinopathy and Lewy pathology
B Sommer, S Barbieri, K Hofele, et al.
Neuropharmacology
|
November 15, 2000
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
K Walker, M Bowes, M Panesar, et al.
Genes, Brain, and Behavior
|
July 29, 2017
Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder
P A Kabitzke, D Brunner, D He, et al.
British Journal of Pharmacology
|
June 10, 2008
Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors
P Malherbe, R Masciadri, R D Norcross, et al.
Neuron
|
August 11, 2001
Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1))
V Schuler, C Lüscher, C Blanchet, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
|
August 26, 2011
PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders
S Saenger, C Goeldner, J R Frey, et al.
Amino Acids
|
October 10, 2002
In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article
R Kuhn, A Pagano, N Stoehr, et al.
British Journal of Pharmacology
|
November 3, 2010
Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors
P Malherbe, F Knoflach, M C Hernandez, et al.
Psychopharmacology
|
December 2, 2010
Dissociable roles of mGlu5 and dopamine receptors in the rewarding and sensitizing properties of morphine and cocaine
M M J Veeneman, H Boleij, M H Broekhoven, et al.
Advances in Experimental Medicine and Biology
|
June 14, 2001
Mouse models of alpha-synucleinopathy and Lewy pathology. Alpha-synuclein expression in transgenic mice
S Barbieri, K Hofele, K H Wiederhold, et al.
Experimental Gerontology
|
December 13, 2000
Mouse models of alpha-synucleinopathy and Lewy pathology
B Sommer, S Barbieri, K Hofele, et al.
Neuropharmacology
|
November 15, 2000
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
K Walker, M Bowes, M Panesar, et al.
Genes, Brain, and Behavior
|
July 29, 2017
Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder
P A Kabitzke, D Brunner, D He, et al.
British Journal of Pharmacology
|
June 10, 2008
Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors
P Malherbe, R Masciadri, R D Norcross, et al.
Neuron
|
August 11, 2001
Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1))
V Schuler, C Lüscher, C Blanchet, et al.
Page
of 2